0001179110-21-011172.txt : 20211221
0001179110-21-011172.hdr.sgml : 20211221
20211221172111
ACCESSION NUMBER: 0001179110-21-011172
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211217
FILED AS OF DATE: 20211221
DATE AS OF CHANGE: 20211221
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schumacher Laura J
CENTRAL INDEX KEY: 0001319245
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35565
FILM NUMBER: 211510292
MAIL ADDRESS:
STREET 1: 1 N. WAUKEGAN ROAD
CITY: NORTH CHICAGO
STATE: IL
ZIP: 60064
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AbbVie Inc.
CENTRAL INDEX KEY: 0001551152
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 320375147
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 NORTH WAUKEGAN ROAD
CITY: NORTH CHICAGO
STATE: IL
ZIP: 60064
BUSINESS PHONE: (847) 932-7900
MAIL ADDRESS:
STREET 1: 1 NORTH WAUKEGAN ROAD
CITY: NORTH CHICAGO
STATE: IL
ZIP: 60064
4
1
edgar.xml
FORM 4 -
X0306
4
2021-12-17
0
0001551152
AbbVie Inc.
ABBV
0001319245
Schumacher Laura J
1 N. WAUKEGAN ROAD
NORTH CHICAGO
IL
60064
0
1
0
0
Vice Chairman
Common Stock, $0.01 par value
2021-12-17
4
M
0
103220
58.88
A
316223
D
Common Stock, $0.01 par value
2021-12-17
4
M
0
78450
54.86
A
394673
D
Common Stock, $0.01 par value
2021-12-17
4
S
0
177556
130.2313
D
217117
D
Common Stock, $0.01 par value
2021-12-17
4
S
0
4114
130.6099
D
213003
D
Option (Right To Buy)
0
2021-12-17
4
M
0
103220
58.88
D
2016-02-19
2025-02-18
Common Stock
103220
0
D
Option (Right To Buy)
0
2021-12-17
4
M
0
78450
54.86
D
2017-02-18
2026-02-17
Common Stock
78450
0
D
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $129.56 to $130.55, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $130.56 to $131.09, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.
These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).
Steven L. Scrogham, attorney-in-fact for Laura J. Schumacher
2021-12-21